Genenta Science SPA (FRA:K5F) Current Deferred Taxes Liabilities: €0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:K5F Genenta Science SPA FRA:K5F
37 GF Score
Price €0.78
! 4 Warning Signs
View Full Analysis

What is Genenta Science SPA Current Deferred Taxes Liabilities?

Genenta Science SPA FRA:K5F +1.30% 37 Current Deferred Taxes Liabilities is €0.00 Mil as of Dec. 2025. GuruFocus rates FRA:K5F with a GF Score™ of 37/100. The stock has 4 warning signs investors should review.

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

Genenta Science SPA's current deferred tax liabilities for the quarter that ended in Dec. 2025 was €0.00 Mil.

Genenta Science SPA Current Deferred Taxes Liabilities Related Terms

Genenta Science SPA Current Deferred Taxes Liabilities Historical Data

* Premium members only.

The historical data trend for Genenta Science SPA's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genenta Science SPA Current Deferred Taxes Liabilities Chart

Genenta Science SPA Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Deferred Taxes Liabilities
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Genenta Science SPA Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Current Deferred Taxes Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:K5F
37GF Score
Genenta Science SPA FRA:K5F
Current Deferred Taxes Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Current Deferred Taxes Liabilities of €0.00 Mil mean?
Genenta Science SPA (FRA:K5F) has a Current Deferred Taxes Liabilities of €0.00 Mil as of Dec. 2025. Current Deferred Tax Liabilities records the total amount of taxes due for the period but not yet paid. View historical data on Genenta Science SPA and its competitors.
Is Genenta Science SPA's Current Deferred Taxes Liabilities too high?
Genenta Science SPA's current Current Deferred Taxes Liabilities is €0.00 Mil. Overall, Genenta Science SPA has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Genenta Science SPA's Current Deferred Taxes Liabilities compare to VRTX and REGN?
Genenta Science SPA's Current Deferred Taxes Liabilities of €0.00 Mil can be compared against companies in the Conglomerates industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Deferred Taxes Liabilities for a Conglomerates company?
A good Current Deferred Taxes Liabilities depends on the Conglomerates industry context. However, Current Deferred Taxes Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Deferred Taxes Liabilities mean?
A high Current Deferred Taxes Liabilities can signal that a stock is expensive relative to its fundamentals. Current Deferred Tax Liabilities records the total amount of taxes due for the period but not yet paid. View historical data on Genenta Science SPA and its competitors. Genenta Science SPA's current Current Deferred Taxes Liabilities is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genenta Science SPA stock overvalued right now?
Genenta Science SPA (FRA:K5F) has a current Current Deferred Taxes Liabilities of €0.00 Mil. The current Current Deferred Taxes Liabilities is €0.00 Mil. Genenta Science SPA's overall GF Score™ is 37/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Deferred Taxes Liabilities calculated?
Current Deferred Taxes Liabilities is calculated from a company's financial statements. For Genenta Science SPA (FRA:K5F), the current Current Deferred Taxes Liabilities is €0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Genenta Science SPA Business Description

Other Exchanges GNTA:USA
Address Via dell’Annunciata No. 31, Milan, ITA, 20121
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon, a product to treat glioblastoma multiforme, a solid tumor affecting the brain.
37GF Score

Get the complete analysis for FRA:K5F

Current Deferred Taxes Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.78
Price